XRCC2 and ovarian carcinoma: In the scope of the German Consortium for Hereditary Breast and Ovarian Cancer, other candidate genes (e.g., NBN, FANCM, XRCC2, and RECQL) are currently co-analyzed for research purposes and their significance in contributing to breast and ovarian cancer is under investigation [3].